December 17, 2006

Please this is old news. The medical community KNOWS that despite taking readings for blood sugar for those on zyrexa (and other "designer" antipsychotics - all designed to make pharmocorporate culture the most profitable business after oil and gas -- the PANCREAS works overtime. PANCREATITIS is the real problem as it cannot be detected until it is TOO LATE. Same with heart failure for many who take this drug.
It is sad commentary to say that parents wake up one morning to find their children, who although "mentally ill", but beloved, DEAD. It is sad commentary to point out that those who end up with the diabetes are often left on zyprexa and their limbs are cut off one at a time -- who wants to lose their children in pieces ....?
Eli Lilly, although now being sued by the State of Miasissippi, continues to plug their drug with soaring profits although they are selling far fewer actual pills. The states and provinces are picking up the tab to buy diabetes drugs made by Lilly.
Soma.
Soma.
Who thought Orwell was talking about atypical antipsychotics ....?

And just wait until the public gets the real news about who actually owns the shares .......
White washing the indefensible. UGH!


http://www.upi.com/NewsTrack/view.php?StoryID=20061216-080002-9034r
NewsTrack - Science

Report: Lilly hid info on Zyprexa
NEW YORK, Dec. 16 (UPI) -- Internal company documents show that Eli Lilly concealed information about side effects of its schizophrenia drug Zyprexa, The New York Times said Saturday.
The Times said it received the documents and e-mails from a lawyer representing patients who have used Zyprexa. They show that the company was warned as early as 1999 that Zyprexa's side effects for many patients included weight gain and an increase in blood sugar, both risk factors for diabetes.
About 2 million people worldwide used Zyprexa last year, spending a total of $4.2 billion. The drug is the company's biggest moneymaker.
In 1999, Dr. Alan Breier, now Lilly's chief medical officer, told more than 20 employees he was setting up an executive committee to study the side effects of olanzapine, the chemical name for Zyprexa.
"Olanzapine-associated weight gain and possible hyperglycemia is a major threat to the long-term success of this critically important molecule," he said in an e-mail.

No comments:

ShareThis